The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To lay down the procedure for performing and documenting weight per mL testing (also referred to as density or specific gravity testing) of elixir formulations during manufacturing, ensuring consistency in batch quality and regulatory compliance.
Click to read the full article.
To define the procedure for preparation, titration, and standardization of pH buffer solutions used during elixir manufacturing and in-process quality control to ensure accurate pH control and compliance with pharmacopeial requirements.
Click to read the full article.
To establish a systematic approach for accurate, complete, and compliant documentation of In-Process Control (IPC) test results during the manufacturing of elixirs. This ensures traceability, supports batch release, and maintains regulatory compliance.
Click to read the full article.
To define the procedure for operation, maintenance, and utilization of Mobile In-Process Control (IPC) Laboratories during elixir manufacturing to enable real-time testing, faster decision-making, and regulatory compliance.
Click to read the full article.
To define the procedure for immediate and structured notification in the event of In-Process Control (IPC) test failures during the manufacturing of elixirs. This ensures timely action, traceability, and regulatory compliance.
Click to read the full article.
To define a systematic approach for the statistical analysis and trending of In-Process Control (IPC) data generated during elixir manufacturing. The objective is to detect variability, identify trends, and ensure process consistency and continuous improvement.
Click to read the full article.
To define the standard procedure for sampling of final elixir product for quality control (QC) testing prior to batch release. This ensures representative, contamination-free sampling and compliance with regulatory and internal requirements.
Click to read the full article.
To describe the procedure for performing quantitative analysis of the Active Pharmaceutical Ingredient (API) in elixir formulations using High-Performance Liquid Chromatography (HPLC), ensuring accuracy, precision, and compliance with pharmacopeial or validated methods.
Click to read the full article.
To establish a standardized procedure for the identification of Active Pharmaceutical Ingredients (APIs) in elixir formulations using Infrared (IR) Spectroscopy. This ensures reliable and accurate confirmation of API identity as per pharmacopeial standards.
Click to read the full article.
To lay down a standardized method for the accurate determination of pH in the final elixir formulation to ensure product stability, patient safety, and compliance with approved specifications.
Click to read the full article.